Primary chemoprevention of familial adenomatous polyposis with sulindac

The New England Journal of Medicine
Francis M GiardielloStanley R Hamilton

Abstract

Familial adenomatous polyposis is caused by a germ-line mutation in the adenomatous polyposis coli gene and is characterized by the development of hundreds of colorectal adenomas and, eventually, colorectal cancer. Nonsteroidal antiinflammatory drugs can cause regression of adenomas, but whether they can prevent adenomas is unknown. We conducted a randomized, double-blind, placebo-controlled study of 41 young subjects (age range, 8 to 25 years) who were genotypically affected with familial adenomatous polyposis but phenotypically unaffected. The subjects received either 75 or 150 mg of sulindac orally twice a day or identical-appearing placebo tablets for 48 months. The number and size of new adenomas and side effects of therapy were evaluated every four months for four years, and the levels of five major prostaglandins were serially measured in biopsy specimens of normal-appearing colorectal mucosa. After four years of treatment, the average rate of compliance exceeded 76 percent in the sulindac group, and mucosal prostaglandin levels were lower in this group than in the placebo group. During the course of the study, adenomas developed in 9 of 21 subjects (43 percent) in the sulindac group and 11 of 20 subjects in the placebo ...Continue Reading

References

Aug 9, 1991·Science·K W KinzlerD McKechnie
Jan 1, 1989·American Journal of Surgery·W R WaddellR W Loughry
Sep 1, 1983·Journal of Surgical Oncology·W R Waddell, R W Loughry
Jan 15, 1994·Lancet·A G ThorsonT C Smyrk
May 6, 1993·The New England Journal of Medicine·F M GiardielloG J Offerhaus
Mar 20, 1997·The New England Journal of Medicine·F M GiardielloS R Hamilton
Jun 30, 2000·The New England Journal of Medicine·G SteinbachG Kelloff
Sep 6, 2000·Nature Medicine·C J TorranceC M Discafani

❮ Previous
Next ❯

Citations

Oct 13, 2007·Inflammatory Bowel Diseases·David T RubinUNKNOWN 5-ASA in Colorectal Cancer Prevention Meeting Group
Nov 17, 2006·International Journal of Colorectal Disease·Janindra Warusavitarne, Margaret Schnitzler
Jun 11, 2005·Cancer Causes & Control : CCC·Lisa L Strate, Sapna Syngal
Jul 1, 2005·Digestive Diseases and Sciences·Hassan AshktorabDuane T Smoot
Oct 24, 2002·Current Treatment Options in Oncology·Angel Ferrández, James A DiSario
Sep 3, 2004·Current Treatment Options in Oncology·Christopher D Lao, Dean E Brenner
May 20, 2004·Current Treatment Options in Gastroenterology·Elizabeth E. Half, Robert S. Bresalier
May 15, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Pedro Pérez SeguraEnrique Aranda
Oct 27, 2004·Critical Reviews in Oncology/hematology·J B TuynmanD J Richel
Dec 31, 2003·Journal of the American College of Surgeons·Robert D Madoff, Sharon L Dykes
Dec 4, 2003·Gastrointestinal Endoscopy·Marcia Cruz-Correa, Francis M Giardiello
Jan 22, 2004·Cancer Genetics and Cytogenetics·Henry T LynchThomas M Attard
Aug 7, 2003·Current Opinion in Pharmacology·Steven J ShiffDiana L Santini
Apr 5, 2003·Best Practice & Research. Clinical Gastroenterology·Brian A Allen, Jonathan P Terdiman
Nov 3, 2005·Nature Clinical Practice. Oncology·Jason R MannRaymond N DuBois
Nov 3, 2005·Nature Clinical Practice. Oncology·Edith D Canby-Hagino, Ian M Thompson
Oct 13, 2006·Nature Reviews. Cancer·Eva Szabo
Dec 21, 2002·Asia Pacific Journal of Clinical Nutrition·Graeme P Young, Richard K Le Leu
Apr 5, 2002·The New England Journal of Medicine·Ian Chau, David Cunningham
Aug 23, 2002·The New England Journal of Medicine·Rafaël Levy
Feb 17, 2005·The New England Journal of Medicine·Scott D SolomonUNKNOWN Adenoma Prevention with Celecoxib (APC) Study Investigators
Sep 1, 2006·The New England Journal of Medicine·Nadir ArberUNKNOWN PreSAP Trial Investigators
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ivana BozicMartin A Nowak
Oct 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·Roland R Regoes
Nov 18, 2005·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Farid E Ahmed
Feb 3, 2005·Genetic Testing·Peter T Rowley
Feb 11, 2005·Current Opinion in Gastroenterology·Elizabeth E Half, Robert S Bresalier
Sep 25, 2003·Journal of Clinical Gastroenterology·Paolo RicchiBruno Daniele
Nov 30, 2006·Current Opinion in Gastroenterology·Irfan M HisamuddinVincent W Yang
Oct 11, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Irfan M HisamuddinVincent W Yang
Aug 19, 2010·Cancer Prevention Research·Emily J GreenspanDaniel W Rosenberg
Dec 7, 2013·BMC Surgery·Francesca NolfoAntonio Biondi
May 15, 2013·Molecular Cancer·Michaela LangChristoph Gasche
Feb 5, 2005·Journal of Translational Medicine·Anna TeseiWainer Zoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.